332 related articles for article (PubMed ID: 38794337)
1. Strategies to Improve the Transdermal Delivery of Poorly Water-Soluble Non-Steroidal Anti-Inflammatory Drugs.
Balmanno A; Falconer JR; Ravuri HG; Mills PC
Pharmaceutics; 2024 May; 16(5):. PubMed ID: 38794337
[TBL] [Abstract][Full Text] [Related]
2. Advanced Drug Delivery Systems for Transdermal Delivery of Non-Steroidal Anti-Inflammatory Drugs: A Review.
Kumar L; Verma S; Singh M; Chalotra T; Utreja P
Curr Drug Deliv; 2018; 15(8):1087-1099. PubMed ID: 29875000
[TBL] [Abstract][Full Text] [Related]
3. Deep Eutectic Solvent Formulations and Alginate-Based Hydrogels as a New Partnership for the Transdermal Administration of Anti-Inflammatory Drugs.
Pedro SN; Mendes MSM; Neves BM; Almeida IF; Costa P; Correia-Sá I; Vilela C; Freire MG; Silvestre AJD; Freire CSR
Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456661
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo Skin Permeation Evaluation of An Innovative Transdermal Vehicle Using Nimesulide and Piroxicam as Model Drugs.
Pereira RO; Pelisson E Silva TCC; de Oliveira Ferreira A; Brandao MAF; Raposo NRB; Polonini HC
Curr Drug Deliv; 2017; 14(4):516-520. PubMed ID: 27557671
[TBL] [Abstract][Full Text] [Related]
5. Formulation of microemulsion gel systems for transdermal delivery of celecoxib: In vitro permeation, anti-inflammatory activity and skin irritation tests.
Soliman SM; Abdel Malak NS; El-Gazayerly ON; Abdel Rehim AA
Drug Discov Ther; 2010 Dec; 4(6):459-71. PubMed ID: 22491312
[TBL] [Abstract][Full Text] [Related]
6. Nanomedicine for the effective and safe delivery of non-steroidal anti-inflammatory drugs: A review of preclinical research.
Al-Lawati H; Binkhathlan Z; Lavasanifar A
Eur J Pharm Biopharm; 2019 Sep; 142():179-194. PubMed ID: 31233861
[TBL] [Abstract][Full Text] [Related]
7. Enhanced transdermal delivery of evodiamine and rutaecarpine using microemulsion.
Zhang YT; Zhao JH; Zhang SJ; Zhong YZ; Wang Z; Liu Y; Shi F; Feng NP
Int J Nanomedicine; 2011; 6():2469-82. PubMed ID: 22072882
[TBL] [Abstract][Full Text] [Related]
8. Microemulsion-based novel transdermal delivery system of tetramethylpyrazine: preparation and evaluation in vitro and in vivo.
Zhao JH; Ji L; Wang H; Chen ZQ; Zhang YT; Liu Y; Feng NP
Int J Nanomedicine; 2011; 6():1611-9. PubMed ID: 21904451
[TBL] [Abstract][Full Text] [Related]
9. Development of liposomal and microemulsion formulations for transdermal delivery of clonazepam: effect of randomly methylated β-cyclodextrin.
Mura P; Bragagni M; Mennini N; Cirri M; Maestrelli F
Int J Pharm; 2014 Nov; 475(1-2):306-14. PubMed ID: 25194352
[TBL] [Abstract][Full Text] [Related]
10. Overcoming Skin Barrier with Transfersomes: Opportunities, Challenges, and Applications.
Dixena B; Madhariya R; Panday A; Ram A; Jain AK
Curr Drug Deliv; 2024 Jan; ():. PubMed ID: 38178667
[TBL] [Abstract][Full Text] [Related]
11. Drug delivery systems. 6. Transdermal drug delivery.
Ranade VV
J Clin Pharmacol; 1991 May; 31(5):401-18. PubMed ID: 2050824
[TBL] [Abstract][Full Text] [Related]
12. Formulation Optimization and Ex Vivo and In Vivo Evaluation of Celecoxib Microemulsion-Based Gel for Transdermal Delivery.
Cao M; Ren L; Chen G
AAPS PharmSciTech; 2017 Aug; 18(6):1960-1971. PubMed ID: 27914040
[TBL] [Abstract][Full Text] [Related]
13. Implementing Nanovesicles for Boosting the Skin Permeation of Non-steroidal Anti-inflammatory Drugs.
Abdelbari MA; Elshafeey AH; Abdelbary AA; Mosallam S
AAPS PharmSciTech; 2023 Sep; 24(7):195. PubMed ID: 37770750
[TBL] [Abstract][Full Text] [Related]
14. Microemulsion: a novel transdermal delivery system to facilitate skin penetration of indomethacin.
Chen L; Tan F; Wang J; Liu F
Pharmazie; 2012 Apr; 67(4):319-23. PubMed ID: 22570938
[TBL] [Abstract][Full Text] [Related]
15. Superiority of microemulsion-based hydrogel for non-steroidal anti-inflammatory drug transdermal delivery: a comparative safety and anti-nociceptive efficacy study.
Mehanna MM; Abla KK; Domiati S; Elmaradny H
Int J Pharm; 2022 Jun; 622():121830. PubMed ID: 35589005
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.
Brown TJ; Hooper L; Elliott RA; Payne K; Webb R; Roberts C; Rostom A; Symmons D
Health Technol Assess; 2006 Oct; 10(38):iii-iv, xi-xiii, 1-183. PubMed ID: 17018227
[TBL] [Abstract][Full Text] [Related]
17. Transdermal delivery of diclofenac using water-in-oil microemulsion: formulation and mechanistic approach of drug skin permeation.
Thakkar PJ; Madan P; Lin S
Pharm Dev Technol; 2014 May; 19(3):373-84. PubMed ID: 23634780
[TBL] [Abstract][Full Text] [Related]
18. Oral non-steroidal anti-inflammatory drugs versus other oral analgesic agents for acute soft tissue injury.
Jones P; Dalziel SR; Lamdin R; Miles-Chan JL; Frampton C
Cochrane Database Syst Rev; 2015 Jul; (7):CD007789. PubMed ID: 26130144
[TBL] [Abstract][Full Text] [Related]
19. Topical Delivery of Meloxicam using Liposome and Microemulsion Formulation Approaches.
Zhang J; Froelich A; Michniak-Kohn B
Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32245190
[TBL] [Abstract][Full Text] [Related]
20. Polymeric Microarray Patches for Enhanced Transdermal Delivery of the Poorly Soluble Drug Olanzapine.
McKenna PE; Abbate MTA; Vora LK; Sabri AH; Peng K; Volpe-Zanutto F; Tekko IA; Permana AD; Maguire C; Dineen D; Kearney MC; Larrañeta E; Paredes AJ; Donnelly RF
ACS Appl Mater Interfaces; 2023 Jul; 15(26):31300-31319. PubMed ID: 37349320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]